These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 30619735)

  • 1. The Use of HPV16-E5, EGFR, and pEGFR as Prognostic Biomarkers for Oropharyngeal Cancer Patients.
    Taberna M; Torres M; Alejo M; Mena M; Tous S; Marquez S; Pavón MA; León X; García J; Guix M; Hijano R; Bonfill T; Aguilà A; Lozano A; Mesía R; Alemany L; Bravo IG
    Front Oncol; 2018; 8():589. PubMed ID: 30619735
    [No Abstract]   [Full Text] [Related]  

  • 2. EGFR Protein Expression Relates with Tumor Histology, Methylation Status of EGFR and HPV16 E6 Viral Load in Oropharyngeal Carcinoma.
    Suzuki Y; Fukumura Y; Asahina M; Fujimaki M; Ohba S; Matsumoto F; Kurahayashi I; Yao T; Ikeda K
    Head Neck Pathol; 2021 Sep; 15(3):743-756. PubMed ID: 33428063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variable expression of the forgotten oncogene E5 in HPV-positive oropharyngeal cancer.
    Um SH; Mundi N; Yoo J; Palma DA; Fung K; MacNeil D; Wehrli B; Mymryk JS; Barrett JW; Nichols AC
    J Clin Virol; 2014 Sep; 61(1):94-100. PubMed ID: 25027574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus 16 E6 antibodies are sensitive for human papillomavirus-driven oropharyngeal cancer and are associated with recurrence.
    Lang Kuhs KA; Kreimer AR; Trivedi S; Holzinger D; Pawlita M; Pfeiffer RM; Gibson SP; Schmitt NC; Hildesheim A; Waterboer T; Ferris RL
    Cancer; 2017 Nov; 123(22):4382-4390. PubMed ID: 28950407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Implication of Persistent Human Papillomavirus Type 16 DNA Detection in Oral Rinses for Human Papillomavirus-Related Oropharyngeal Carcinoma.
    Rettig EM; Wentz A; Posner MR; Gross ND; Haddad RI; Gillison ML; Fakhry C; Quon H; Sikora AG; Stott WJ; Lorch JH; Gourin CG; Guo Y; Xiao W; Miles BA; Richmon JD; Andersen PE; Misiukiewicz KJ; Chung CH; Gerber JE; Rajan SD; D'Souza G
    JAMA Oncol; 2015 Oct; 1(7):907-15. PubMed ID: 26226294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concordance of p16
    Mena M; Wang X; Tous S; Quiros B; Clavero O; Alejo M; Morey F; Taberna M; Leon Vintro X; Lloveras Rubio B; Alos L; Mehanna H; Quint W; Pawlita M; Tommasino M; Pavón MA; Muñoz N; De Sanjose S; Bosch FX; Alemany L; On Behalf Of The Ico International Hpv In Head And Neck Cancer Study Group
    Cancers (Basel); 2022 Aug; 14(15):. PubMed ID: 35954451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double positivity for HPV-DNA/p16
    Mena M; Taberna M; Tous S; Marquez S; Clavero O; Quiros B; Lloveras B; Alejo M; Leon X; Quer M; Bagué S; Mesia R; Nogués J; Gomà M; Aguila A; Bonfill T; Blazquez C; Guix M; Hijano R; Torres M; Holzinger D; Pawlita M; Pavon MA; Bravo IG; de Sanjosé S; Bosch FX; Alemany L
    Oral Oncol; 2018 Mar; 78():137-144. PubMed ID: 29496041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPV16 antibodies as risk factors for oropharyngeal cancer and their association with tumor HPV and smoking status.
    Anderson KS; Dahlstrom KR; Cheng JN; Alam R; Li G; Wei Q; Gross ND; Chowell D; Posner M; Sturgis EM
    Oral Oncol; 2015 Jul; 51(7):662-7. PubMed ID: 25957822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E1 detection as prognosticator in human papillomavirus-positive head and neck cancers.
    Vivenza D; Lo Nigro C; Denaro N; Fortunato M; Monteverde M; Tonissi F; Lattanzio L; Astesana V; Gloghini A; Volpi CC; Russi E; Merlano MC
    Int J Biol Markers; 2016; 31(2):0. PubMed ID: 27040135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPV16 E6/E7 expression in circulating tumor cells in oropharyngeal squamous cell cancers: A pilot study.
    Economopoulou P; Koutsodontis G; Avgeris M; Strati A; Kroupis C; Pateras I; Kirodimos E; Giotakis E; Kotsantis I; Maragoudakis P; Gorgoulis V; Scorilas A; Lianidou E; Psyrri A
    PLoS One; 2019; 14(5):e0215984. PubMed ID: 31071126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab.
    Rosenthal DI; Harari PM; Giralt J; Bell D; Raben D; Liu J; Schulten J; Ang KK; Bonner JA
    J Clin Oncol; 2016 Apr; 34(12):1300-8. PubMed ID: 26712222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EGFR overexpression and macrophage infiltration correlate with poorer prognosis in HPV-negative oropharyngeal cancer via STAT6 signaling.
    Lee HP; Li CJ; Lee CC
    Head Neck; 2024 Jun; 46(6):1294-1303. PubMed ID: 38497289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on human papillomavirus (HPV) 16 E2, E5 and E7 mRNA in HPV-positive tonsillar and base of tongue cancer in relation to clinical outcome and immunological parameters.
    Ramqvist T; Mints M; Tertipis N; Näsman A; Romanitan M; Dalianis T
    Oral Oncol; 2015 Dec; 51(12):1126-31. PubMed ID: 26421862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of human papillomavirus antibodies in individuals with head and neck cancer.
    Lang Kuhs KA; Pawlita M; Gibson SP; Schmitt NC; Trivedi S; Argiris A; Kreimer AR; Ferris RL; Waterboer T
    Cancer Epidemiol; 2016 Jun; 42():46-52. PubMed ID: 27010729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The papillomavirus E5 gene does not affect EGFR transcription and overall survival in cervical cancer.
    Basto DL; Chaves CBP; Felix SP; Amaro-Filho SM; Vieira VC; Martins LFL; de Carvalho NA; Almeida LM; Moreira MÂM
    J Med Virol; 2020 Aug; 92(8):1283-1289. PubMed ID: 31696949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of stage I HPV-driven oropharyngeal cancer in asymptomatic individuals in the Hamburg City Health Study using HPV16 E6 serology - A proof-of-concept study.
    Busch CJ; Hoffmann AS; Viarisio D; Becker BT; Rieckmann T; Betz C; Bender N; Schroeder L; Hussein Y; Petersen E; Jagodzinski A; Schäfer I; Burandt E; Lang Kuhs K; Pawlita M; Waterboer T; Brenner N
    EClinicalMedicine; 2022 Nov; 53():101659. PubMed ID: 36147627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus DNA load and p16INK4a expression predict for local control in patients with anal squamous cell carcinoma treated with chemoradiotherapy.
    Rödel F; Wieland U; Fraunholz I; Kitz J; Rave-Fränk M; Wolff HA; Weiss C; Wirtz R; Balermpas P; Fokas E; Rödel C
    Int J Cancer; 2015 Jan; 136(2):278-88. PubMed ID: 24839133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between epidermal growth factor receptor status, p16(INK4A), and outcome in head and neck squamous cell carcinoma.
    Young RJ; Rischin D; Fisher R; McArthur GA; Fox SB; Peters LJ; Corry J; Lim A; Waldeck K; Solomon B
    Cancer Epidemiol Biomarkers Prev; 2011 Jun; 20(6):1230-7. PubMed ID: 21467228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics and outcomes of oropharyngeal carcinoma related to high-risk non-human papillomavirus16 viral subtypes.
    Varier I; Keeley BR; Krupar R; Patsias A; Dong J; Gupta N; Parasher AK; Genden EM; Miles BA; Teng M; Bakst RL; Gupta V; Misiukiewicz KJ; Chiao EY; Scheurer ME; Laban S; Zhang D; Ye F; Cui M; Demicco EG; Posner MR; Sikora AG
    Head Neck; 2016 Sep; 38(9):1330-7. PubMed ID: 27080140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer.
    Reimers N; Kasper HU; Weissenborn SJ; Stützer H; Preuss SF; Hoffmann TK; Speel EJ; Dienes HP; Pfister HJ; Guntinas-Lichius O; Klussmann JP
    Int J Cancer; 2007 Apr; 120(8):1731-8. PubMed ID: 17236202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.